Nobilis CAV P4
Nobilis CAV P4
Authorised
- Chicken anaemia virus, strain 26P4, Live
Product identification
Medicine name:
Nobilis CAV P4
Active substance:
- Chicken anaemia virus, strain 26P4, Live
Target species:
-
Chicken
Route of administration:
-
Wing-web-stab use
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Chicken anaemia virus, strain 26P4, Live3.00/log10 50% tissue culture infectious dose1.00Dose
Pharmaceutical form:
-
Lyophilisate for suspension for injection
Withdrawal period by route of administration:
-
Wing-web-stab use
-
Chicken
-
Meat and offalno withdrawal period
-
Eggno withdrawal period
-
-
-
Intramuscular use
-
Chicken
-
Meat and offal0day
-
Egg0day
-
-
-
Subcutaneous use
-
Chicken
-
Meat and offal0day
-
Egg0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Portugal
Available in:
-
Portugal
Package description:
- Cardboard box with 1 x 1000 doses Lyophilisate: 10 ml glass vial (type I) with halogenobutyl rubber stopper and coded aluminium capsule
- Cardboard box with 1 x 13 ml solvent Unisolve: 20 ml glass vial (type II) with halogenobutyl rubber stopper and coded aluminium capsule
- Cardboard box with 1 x 200 ml solvent Dilavia: 250 ml glass (type II) or PET vial with halogenobutyl rubber stopper and coded aluminium capsule
- Cardboard box with 10 x 1000 doses of vaccine - Lyophilisate: 10 ml glass vial (type I) with halogenobutyl rubber stopper and coded aluminium capsule
- Cardboard box with 10 x 13 ml solvent Unisolve: 20 ml glass vial (type II) with halogenobutyl rubber stopper and coded aluminium capsule.
- Cardboard box with 10 x 200 ml solvent Dilavia: 250 ml glass (type II) or PET vial with halogenobutyl rubber stopper and coded aluminium capsule
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- MSD Animal Health Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Directorate General For Food And Veterinary
Authorisation number:
- 561/96 DGV
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/8659/001
Concerned member states:
-
Belgium
-
Denmark
-
Finland
-
Germany
-
Portugal
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 26/08/2024